Advanced dual primary male breast cancer and lung cancer: A case report and literature review
The current report presents a unique case of advanced male invasive breast cancer coexisting with synchronous primary lung adenocarcinoma, a rare clinical manifestation. The case contributes to the limited literature on male breast cancer and its association with multiple primary malignancies. The patient, a 59-year-old man, presented with a large ulcerative mass in the left breast (14×10 cm) and ground-glass opacities with calcified nodules in the right lower lung lobe (14×14 mm). Imaging and pathology confirmed stage IIIB invasive ductal carcinoma of the breast [human epidermal growth factor receptor-2-positive, estrogen receptor-positive (80%) and progesterone receptor-positive (5%)] and minimally invasive lung adenocarcinoma. Treatment consisted of neoadjuvant chemotherapy (epirubicin + carboplatin + trastuzumab + pertuzumab), a modified radical mastectomy with latissimus dorsi flap reconstruction and a thoracoscopic lung wedge resection. The therapeutic approach resulted in partial remission of the breast cancer prior to surgery and a stable disease status in the lung, with no recurrence at the 1-year follow-up. This case underscores the importance of comprehensive, integrative strategies and long-term follow-up for managing rare, complex cancer cases.
Authors
- Daixiang Liao (ORCID: https://orcid.org/0009-0004-6446-4469)
- Xiaoxiao Xing (ORCID: https://orcid.org/0000-0002-4862-5822)
- Shiyun Zhang (ORCID: https://orcid.org/0000-0002-2623-1283)
- Dongpo Zhang
- Jun Li (ORCID: https://orcid.org/0000-0002-7236-8088)
- Yun Wang (ORCID: https://orcid.org/0000-0001-7146-8290)
- Yue Wang
- Xia Li (ORCID: https://orcid.org/0000-0002-9794-2648)
Institutions
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- Guang’anmen Hospital (CN)
Publication Details
- Journal
- Oncology Letters
- Published
- 2025-10-22
- DOI
- https://doi.org/10.3892/ol.2025.15355
- Primary Topic
- Male Breast Health Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00